Doctors want liability shield from AI mistakes
A national physicians group is lobbying for new liability protections as AI is rapidly deployed in healthcare, seeking to shield doctors when AI causes harm and to assign fault to developers, vendors, or health systems rather than clinicians. They call for laws requiring AI companies to carry liability insurance and disclose limitations and performance data. The push reflects concerns over triage errors, misleading AI-driven recommendations based on incomplete inputs, and the challenge of verifying AI outputs in real-time. The effort aims to shape accountability as courts weigh multi-party responsibility, with regulators and industry groups weighing appropriate oversight and post-market monitoring. The outcome could redefine who bears risk as AI tools become more embedded in care pathways.
Dive Deeper:
The AMA is advocating for legal protections that would shield physicians from liability when AI systems contribute to patient harm, while also assigning responsibility to AI developers, vendors, and health systems that mandate specific AI tools.
Experts warn of triage errors where AI analyzes clinical data and misjudges case severity without the attending physician's awareness, highlighting risks in automation replacing nuanced human judgment.
Concerns persist that AI may make plausible treatment recommendations using incomplete lab results or outdated diagnoses, leaving physicians unable to verify critical inputs before acting.
Previously, liability often rested with doctors because licensing terms left final medical decisions to clinicians, reducing accountability for software developers in such scenarios.
Accountability in AI-enabled care hinges on how fault is distributed across multiple parties involved in building and deploying the system, how to establish responsibility for opaque models, and what recourse exists when damages emerge post-deployment.
Regulators and industry groups are weighing the FDA’s role in overseeing generative AI-enabled medical tools, with hospitals pushing to place accountability on developers and vendors, while AdvaMed seeks to limit burdensome post-market monitoring.